Dr. Reddy’s Laboratories informs about updates

28 Oct 2023 Evaluate

Dr. Reddy’s Laboratories has informed that the United States Food & Drug Administration (USFDA) completed a routine cGMP inspection at its formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from October 19, 2023 to October 27, 2023. The company has been issued a Form 483 with ten observations, which will address within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1235.15 18.00 (1.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×